|
End-of-day quote
Mexican S.E.
25/08/2026
|
5-day change | 1st Jan Change | ||
| 2,520.00 MXN | +1.82% |
|
+5.52% | +13.40% |
| 08-25 | Wall Street Wants Receipts | |
| 08-25 | Lakefront Biotherapeutics, Gilead Secure Another Orphan Drug Designation for Skin Disorder Drug in US | MT |
Chart: Technical Analysis
Stock exchange
Mexican S.E.
GILD * 2,520.00 $
+1.82%
17.64K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| GILD | 148.09USD | -0.46% | 779M $ | |
CBOE
| GILD | 148.10USD | -0.44% | 17.01M $ | |
Tradegate
| GIS | 124.60EUR | -1.95% | 259K € | |
Xetra
| GIS | 127.52EUR | +0.58% | 95.77K € | |
Boerse Muenchen
| GIS | 125.14EUR | -1.65% | 32.91K € | |
Wiener Boerse
| GILD | 124.90EUR | -0.95% | 26.48K € | |
Lima
| GILDUS | 147.11USD | +5.90% | 6.47K $ | |
Deutsche Boerse AG
| GIS | 127.44EUR | +0.19% | 3.19K € | |
Mexican S.E.
| GILD * | 2,520.00MXN | +1.82% | 17.64K $ | |
London S.E.
| 0QYQ | 148.50USD | +1.37% | 445.5 $ | |
Borsa Italiana
| 1GILD | 127.48EUR | +0.44% | 0 € | |
Börse Stuttgart
| GIS | 125.62EUR | -1.69% | 0 € | |
Santiago S.E.
| GILD | 138.92USD | 0.00% | 0 $ | |
Swiss Exchange
| GILD | 147.40USD | +0.16% | 0 $ | |
Santiago S.E.
| GILDCL | 134,210.00CLP | +5.68% | 0 $ | |
Swiss Exchange
| GILD | 118.74CHF | +0.51% | 0 CHF | |
CBOE
| 0QYQ | 126.24EUR | 0.00% | 0 € | |
CBOE
| 126.44EUR | 0.00% | 0 € | ||
Sao Paulo
| GILD34 | 63.72BRL | +1.43% | 28.29K R$ | |
Buenos Aires S.E.
| GILD | 59,500.00ARS | +1.54% | 28.56M $ | |
Buenos Aires S.E.
| GILDD | 38.60USD | +5.01% | 5.25K $ | |
Toronto S.E.
| GILD | 30.07CAD | +0.17% | 29.32K $ | |
Deutsche Boerse AG
| GIS0 | 18.40EUR | +1.66% | 0 € |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- GILD Stock
- GILD * Stock
- Charts Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions

















